“COST ANALYSIS OF PATIENTS WITH SQUAMOUS CELL CERVICAL CANCER STAGE IIB-IIIB WITH PACLITAXEL CISPLATIN CHEMOTHERAPY FROM THE SOCIETAL PERSPECTIVE”, JPSA, vol. 5, no. 1, pp. 34–44, Jun. 2023, doi: 10.24843/JPSA.2023.v05.i01.p05.